Caprylates

• 

  Subject Areas on Research

  • Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. 
  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. 
  • Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. 
  • Directed evolution of a pyruvate aldolase to recognize a long chain acyl substrate. 
  • Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility. 
  • Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX). 
  • Exposure of developing chicks to perfluorooctanoic acid induces defects in prehatch and early posthatch development. 
  • Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. 
  • Formation of a free acyl adenylate during the activation of 2-propylpentanoic acid. Valproyl-AMP: a novel cellular metabolite of valproic acid. 
  • Identification and localization of the fatty acid modification in ghrelin by electron capture dissociation. 
  • Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver. 
  • Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation. 
  • Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model. 
  • Per- and Polyfluoroalkyl Substances in Dust Collected from Residential Homes and Fire Stations in North America. 
  • Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. 
  • Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). 
  • Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES). 
  • Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility. 
  • Serum perfluoroalkyl acids (PFAAs) and associations with behavioral attributes. 
  • Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.